Monday, August 4, 2025

Ambuja Cements Q1 Results: Volume growth aids topline, margin expands

Date:

Ambuja Cements’ first quarter earnings beat estimates on Thursday, July 31. The stock came in for mild profit taking, declining over 3%.The company reported a net profit of ₹970 crore in the first quarter in comparison to a CNBC-TV18 poll of ₹796 crore. It was also 23.5% more than the previous year’s ₹783 crore.
The company’s revenue increased 23% to ₹10,289 crore from ₹8,932 crore in the year-ago period. This was also higher than Street estimates of ₹9,493 crore.
Ambuja Cements’ earnings before interest, taxes, depreciation and amortisation (EBITDA) came in at 1,961 crore in the June quarter. This was 53% more than the previous year’s ₹1,280 crore, while the Street had estimated an EBITDA of ₹1,844 crore.
The company’s margin expanded to 19.05% from the previous year’s 15.25%. The CNBC-TV18 poll had estimated a margin of 19.42% in the June quarter.The company’s topline beat was aided 20% increase in volumes at 18.4 MT compared to 15.3 MT in the previous year. Its EBITDA per tonne also increased 28% to ₹1,069 per tonne in the June quarter from ₹835 per tonne in the previous year.

Ambuja Cements commissioned 57 MW wind power in the first quarter, taking its renewable energy capacity to 473 MW.

The company continues to remain debt free.

The present cement capacity of 104.5 MTPA is well poised to achieve planned capacity of 118 MTPA by March 2026.

Ambuja Cements shares were trading 3.46% lower at ₹596.45 apiece. The stock has gained 10.8% this year, so far.

Source link

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Share post:

Subscribe

spot_imgspot_img

Popular

More like this
Related

MCX share price jumps 4% after strong Q1 results 2025, stock split announcement. Do you own?

मल्टी कमोडिटी एक्सचेंज ऑफ इंडिया (MCX) शेयर की कीमत...

Crude oil prices could harden if India stops buying Russian oil: Sources

Crude oil prices may surge if India halts its...

Sun Pharma Q1 Results: US sales meet expectations; one-off drags profit

Sun Pharma Ltd. India's largest drugmaker, reported June quarter...